CIK 0001053691 · Non-accelerated filer<br>Smaller reporting company
CervoMed Inc.
Sign in to watch- Ticker
- CRVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300645032
- Phone
- (617) 744-4400
- Business address
- 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Former names
- Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-13 | Giles Mark T Director | Grant or award · Stock Option (Right to Buy) | +19,200 | 19,200 | ||
| 2019-06-13 | LEVIN ALAN G Director | Grant or award · Stock Option (Right to Buy) | +19,200 | 19,200 | ||
| 2019-06-13 | Adams Robert W Director | Grant or award · Stock Option (Right to Buy) | +13,100 | 13,100 | ||
| 2019-06-13 | LEVIN ALAN G Director | Grant or award · Stock Option (Right to Buy) | +13,100 | 13,100 | ||
| 2019-06-13 | Giles Mark T Director | Grant or award · Stock Option (Right to Buy) | +13,100 | 13,100 | ||
| 2019-01-03 | Byrne Thomas E General Counsel | Grant or award · Stock Option (Right to Buy) | +2,667 | 2,667 | ||
| 2019-01-02 | Hornung William Karl Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +16,334 | 16,334 | ||
| 2018-06-14 | Adams Robert W Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-06-14 | Giles Mark T Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-06-14 | LEVIN ALAN G Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-06-14 | RUFFOLO ROBERT R Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-01-02 | Byrne Thomas E General Counsel | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-01-02 | Shealy Ben Sr VP Finance & Treasurer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-01-02 | LEVIN ALAN G Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-01-02 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2018-01-02 | RUFFOLO ROBERT R Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-01-02 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2018-01-02 | Adams Robert W Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-01-02 | Giles Mark T Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-06-29 | RUFFOLO ROBERT R Director | Grant or award · Stock Option (Right to Buy) | +52,057 | 52,057 |
Page 10 of 17 · 321 trades